Want more tips and tricks for reaching your health goals? Join Lark!

Take our 2-minute survey to find out if you’re eligible to join Lark which includes a smart scale and the chance to earn a Fitbit®.
Start now
*Terms and conditions apply
Close icon

Interested in more health & wellness content from Lark? Let’s stay in touch.

Sign up below for more information from Lark
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Close icon
< Back to Resource Center
< Back to Member Blog

Exploring Weight Management and Obesity Strategies at the California Association of Health Plans Event

Lark
Team
December 11, 2023
Exploring Weight Management and Obesity Strategies at the California Association of Health Plans Event
Lark

Are you at risk of prediabetes?

Lark can help lower your risk for Type 2 Diabetes through healthy habit formation, and data tracking.
Height: 5 ft 4 in
4' 0"
7' 0"
Weight: 160 lbs
90 lbs
500 lbs
LOW RISK
Risk Level
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

What could 15% weight loss mean for you?

Feel more energetic and significantly reduce your risk of chronic conditions like diabetes and cardiovascular disease.

By clicking the button above, you agree to the Lark Terms & Conditions, Privacy Policy, and SMS Terms.

Current Weight: 250 lbs
120 lbs
500 lbs
Your weight loss could be*
- - lbs
Your new weight: -- lbs
Am I eligible?

By clicking the button above, you agree to the Lark Terms & Conditions, Privacy Policy, and SMS Terms.

*Results may vary. Based on the average weight loss in three, 68-week clinical trials of patients without diabetes who reached and maintained a dose of 2.4mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity. View study here.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

The 2023 California Association of Health Plans conference was an innovative and collaborative experience for the California healthcare industry. Lark enjoyed the opportunity to catch up with our industry peers for enlightening conversations on the ever-evolving landscape of healthcare, specifically the emergence of weight loss medications. After three days of presentations, meetings and networking, the panel on obesity strategies was our standout perspective from the event.

Titled Obesity: Strategies & Considerations for New Treatment, this panel of experts, featured Daphne Miller, MD of LifeLong Medical Center, Ian Duncan, PHD of Santa Barbara Actuaries Inc., and Dennis Hsieh, MD, JD of Central California Alliance of Health. The panelists delved into various aspects of weight management, obesity treatment, and the challenges faced by the healthcare industry. 

Three Distinct Perspectives

Dr. Duncan started the conversation by discussing an overlooked concern about the escalating cost of GLP1 medication. He presented a cross-sectional study demonstrating that although patients taking GLP-1s experienced a decrease in BMI, the overall cost of their care did not diminish all else staying equal. In fact, health plans are paying anywhere from $14,000 to $15,000 per year per patient on GLP-1s, before discounts and rebates. 

He emphasized that weight reduction might not be the primary avenue to lower healthcare costs for a vast range of patients and advocated for a more targeted approach to authorizing GLP-1s based on individual BMI brackets— further highlighting that health plans should be looking to vendor partners that help with responsible treatment triaging, lifestyle modification coaching, and processes around authorization requirements. 

Next up was Dr. Miller who addressed that GLP-1 treatments are not one-size-fits-all for weight loss and the need for individualized approaches to address weight challenges. She highlighted the importance of coaching and guidance to support diet and lifestyle from a community perspective, endorsing the "Food is Medicine" approach. Furthermore, Miller underscored the significance of addressing social determinants of health (SDoHs) and partnering with vendors who contribute to the betterment of the community. 

One of Miller's striking points was the significant role of zip codes in predicting health outcomes. She emphasized that changing one's zip code could have the most profound impact on metabolic health. This really resonated with Lark, because we have a long history of proven clinical outcomes in HPSAs. Additionally, group medical visits or social groups, such as a vibrant Facebook community that fosters member support and collaboration, were highlighted as solutions to overcome access issues.

Lastly, Dr. Hseih was focused on measuring the efficiency of GLP-1s and how to tackle the challenges associated with behavior change. He acknowledged that while wellness challenge programs, like "Couch to 5k", are often difficult to implement successfully, behavior-change programs to address obesity-related conditions were a starting point. 

In conclusion, the California Association of Health Plans further emphasized the impact that obesity medications have had on weight management, obesity treatment, and more broadly, the future of healthcare. The insights shared by the panelists served as a reminder of the complexities and nuances involved in addressing weight management and health, ultimately highlighting the need for innovative, holistic, and member-centric approaches to tackle these pressing issues. 

Learn more about our weight management solutions today by downloading our one-pager

About Lark

Lark helps you eat better, move more, stress less, and improve your overall wellness. Lark’s digital coach is available 24/7 on your smartphone to give you personalized tips, recommendations, and motivation to lose weight and prevent chronic conditions like diabetes.

Read more

Get healthier with Lark & earn a Fitbit®

Lose weight, get more active, and eat better.
take 1-minute survey

See if Ozempic® is covered by insurance

Curb cravings and reach your weight loss goals!
AM I ELIGIBLE?

Similar posts

Employers Must Brace for 2024 GLP-1 Cost ConundrumEmployers Must Brace for 2024 GLP-1 Cost Conundrum

Employers Must Brace for 2024 GLP-1 Cost Conundrum

The surge in employee demand for GLP-1 medications has presented organizations with an ongoing dilemma of coverage. And this will be exacerbated with the looming arrival of oral GLP-1s3 that will like

Learn more
GLP-1s Are Only One Part of The Obesity PuzzleGLP-1s Are Only One Part of The Obesity Puzzle

GLP-1s Are Only One Part of The Obesity Puzzle

We all know the sobering statistics: approximately 42% of adults in the U.S. currently have obesity1 and that number is expected to rise to 1 in 2 adults by 2030.

Learn more